![]() |
市场调查报告书
商品编码
1500263
代谢检测市场:按产品、技术、应用和最终用户划分 - 全球预测 2024-2030Metabolism Assays Market by Product (Assay Kits & Reagents, Instruments & Analyzers), Technology (Colorimetry, Fluorimetry, Spectrometry), Application, End User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年代谢检测市场规模为16.6亿美元,预计2024年将达17.8亿美元,2030年将达27.6亿美元,复合年增长率为7.51%。
代谢测定用于鑑定与肝臟代谢相关的化学结构的代谢稳定性。代谢测定是一种分析技术,旨在测量和量化细胞、组织或整个生物体中发生的生化过程。这些测定为控制不同生物功能的代谢途径提供了宝贵的见解,例如能量产生、细胞生长、废物清除和对环境压力的反应。代谢测定在药物发现和开发、毒性研究、营养分析、疾病诊断和治疗监测等多种研究领域中至关重要。随着心血管疾病 (CVD)、糖尿病、肥胖和癌症等与文明病在全球范围内持续增加,针对潜在代谢异常的新型治疗性介入的需求日益增长。个人化医疗的日益普及和研究活动的增加预计将推动市场成长。然而,先进技术和分析设备的成本高昂,以及缺乏标准化的测量程序,可能会阻碍市场需求。最尖端科技的市场开拓以及对研发活动的投资不断增加,正在扩大以高灵敏度和分辨率研究各种生物系统中代谢途径的能力,为代谢检测市场创造利润丰厚的机会。
主要市场统计 | |
---|---|
基准年[2023] | 16.6亿美元 |
预测年份 [2024] | 17.8亿美元 |
预测年份 [2030] | 27.6亿美元 |
复合年增长率(%) | 7.51% |
区域洞察
由于对生物医学研究的重视以及肥胖和糖尿病等代谢性疾病的高盛行率,美洲的市场格局正在发生显着变化。美国国立卫生研究院 (NIH) 正在投资代谢研究,以提高我们对身体活动如何在分子层面上影响人类健康的理解。欧洲、中东和非洲地区对代谢检测的需求是由欧盟国家推动的。欧洲生物技术公司正在积极申请与代谢测定相关的专利,欧洲各地的政府资助生命科学研究正在支持众多倡议,以更好地了解代谢途径和相关疾病。非洲和中东地区对医疗基础设施的投资不断增加,并采用先进的代谢分析诊断技术。由于公共和私营部门对医疗保健研发的投资增加,亚太地区正在经历新兴市场格局。此外,政府还启动了多个代谢疾病研究支持计划,以确定代谢疾病的新药物标靶。
FPNV定位矩阵
FPNV 定位矩阵对于评估代谢检测市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对代谢分析市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对公司目前在代谢检测市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[191 Pages Report] The Metabolism Assays Market size was estimated at USD 1.66 billion in 2023 and expected to reach USD 1.78 billion in 2024, at a CAGR 7.51% to reach USD 2.76 billion by 2030.
A metabolic assay is used to identify metabolic stability in chemical structures in connection with hepatic metabolism. Metabolism assays are analytical techniques designed to measure and quantify the biochemical processes occurring within cells, tissues, or whole organisms. These assays provide valuable insights into metabolic pathways that regulate diverse biological functions such as energy production, cell growth, waste removal, and response to environmental stressors. Metabolism assays are crucial in various research fields, including drug discovery and development, toxicology studies, nutrition analysis, disease diagnosis, and treatment monitoring. As the global incidence of lifestyle-related disorders such as cardiovascular diseases (CVDs), diabetes, obesity, and cancer continues to increase, there is an increasing need for novel therapeutic interventions targeting underlying metabolic abnormalities. Growing adoption of personalized medicine and rising research actions are expected to fuel the market growth. However, the High costs of advanced technologies and analytical instruments and the Lack of standardization in assay procedures may hamper the market demand. The ongoing development of cutting-edge technologies and rising investments in R&D activities have expanded the capabilities for studying metabolic pathways at high sensitivity and resolution across various biological systems, significantly creating a lucrative opportunity in the metabolism assay market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.66 billion |
Estimated Year [2024] | USD 1.78 billion |
Forecast Year [2030] | USD 2.76 billion |
CAGR (%) | 7.51% |
Regional Insights
The Americas has a significant landscape in the metabolism assays market owing to its strong focus on biomedical research and a higher prevalence of metabolic diseases such as obesity and diabetes. The investment by the National Institutes of Health (NIH) in metabolic research to advance understanding of how physical activity affects human health at a molecular level. EU countries are key players in driving demand for metabolism assays within the EMEA region. European biotech companies have been actively filing patents related to metabolism assays; government funding for life science research across Europe has led to numerous initiatives to better understand metabolic pathways and disorders. In Africa and the Middle East, growing investments in healthcare infrastructure have led to increased adoption of advanced metabolism assay diagnostic techniques. The APAC region has a developing landscape in the metabolism assays market owing to increasing investment in healthcare R&D by both public and private entities. Moreover, the Government has initiated several metabolic disease research supporting projects to identify novel drug targets for metabolic diseases.
Market Insights
The market dynamics represent an ever-changing landscape of the Metabolism Assays Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Metabolism Assays Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Metabolism Assays Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
A new image-based cellular profiling tool peers deeply into metabolic biology
The Broad Institute has developed Lipocyte Profiler, a cutting-edge metabolic biology tool to enhance understanding of metabolism assays. This innovative tool allows for the rapid execution of hundreds of assay conditions in a single experiment, providing researchers with unprecedented data points. Moreover, it boasts improved cell growth capabilities when compared to traditional methods. [Published On: 2023-06-30]
MU bags Indian patent for low-cost Colorimeter
Mumbai University obtained a patent for a cost-effective colorimeter device for conducting metabolism assays. This device offers accuracy and ease of use and requires minimal maintenance. As a result of this innovative technology, research centers now have the opportunity to carry out metabolic experiments with improved accuracy at an affordable cost. [Published On: 2023-02-11]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Metabolism Assays Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Metabolism Assays Market, highlighting leading vendors and their innovative profiles. These include 3H Biomedical AB, Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., AMSBIO, BioAssay Systems, BIOTREN, BMG LABTECH GmbH, BPS Bioscience, Inc., Cayman Chemical Company, Chondrex, Inc., Creative Bioarray, Elabscience Biotechnology Inc., EMELCA Bioscience, Enzo Life Sciences, Inc., Eton Bioscience, Inc., Kaneka Eurogentec S.A., Merck KGaA, Ncardia Services BV, NOVOCIB, Promega Corporation, RayBiotech Life, Inc., Sartorius AG, Tempo Bioscience, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
TABLE